Total Funding
2
33
Total FundingVenture - Series Unknown raised
Growth Score
-13 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
733981
NeoDiagnostix is committed to pioneering the field of personalized medicine through cancer genomics.
Richard M. Pinnola: President & CEO
About the Company
NeoDiagnostix is committed to pioneering the field of personalized medicine through cancer genomics. By combining the most advanced diagnostics with therapeutics, we enable clinicians to determine the best course of treatment for the patient. NeoDiagnostix is merging the most advanced molecular DNA technologies with a substantial portfolio of
proprietary biomarkers that have been closely linked to oncologic disease. We are committed to providing clinicians with a patient specific molecular profile that will provide crucial insights into cancer leading to improved or individualized patient care.
